Arthritis Patients – Cigna’s Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of $3,500 yearly.
FDA Green Lights Pfizer’s Gene Therapy For Rare Bleeding Disorder Hemophilia
FDA approves Pfizer's Beqvez for adults with hemophilia B, offering a one-time treatment to produce FIX. Experience reduced bleeding frequency. Explore Pfizer's warranty program.
Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What’s Driving Markets Friday?
Strong earnings reports from Alphabet Inc. (NASDAQ:GOOGL) and Microsoft Corp. (NASDAQ:MSFT) have restored positive sentiment in the market, sweeping away fears of increasing risks of stagflation that had
Production Up, Profit Down: Imperial Oil Navigates Seasonal Trends In Q1
Imperial Oil reported higher first-quarter EPS and Upstream production, but lower net income. Dividend declared and carbon capture project initiated.
US Energy Stocks Fall Following Oil Giants’ Subdued Earnings Reports
U.S. energy stocks decline after disappointing earnings from Exxon Mobil and Chevron. Energy sector ETF XLE sees worst session since Jan.
Why Is HCA Healthcare Stock Trading Lower On Friday?
HCA Healthcare's first-quarter results, surpassing revenue and EPS expectations. CEO Sam Hazen emphasizes sustained momentum and volume growth.
Why Petroleum Refineries Major Phillips 66 Shares Are Falling Today
Phillips 66 reported Q1 FY24 results with revenue of $36.436B and adjusted EPS of $1.90 missing consensus of $2.17.
Ex-Humira Growth Platform Drives AbbVie’s Q1 Performance, Drugmaker Lifts Annual Profit Outlook
AbbVie impresses with Q1 results: EPS beats at $2.31 (-6.1% Y/Y), net revenue exceeds at $12.31 billion (+0.7%). Notable: Immunology sales, Humira vs. biosimilars, oncology gains.
Exxon Mobil’s Stock Slides Following Q1 Earnings – Here’s Why
Exxon Mobil reported Q1 results, beating revenue expectations. Net profit down due to refining margins and gas prices. Declares dividend.
Anglo American Rejects BHP’s ‘Highly Unattractive’ Bid, Sets Proposal Deadline For May 22
"The BHP proposal is opportunistic and fails to value Anglo American's prospects," the board chair said.